GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medicalgorithmics MDG.WA · PLN

Health Care · GPW · 🇵🇱 Poland

Compare

20.70

0.00%

Close of 9 Nov 2026, in PLN

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medicalgorithmics

Its shares trade on GPW under the ticker MDG.WA. It has been listed since 9 November 2011. In the fiscal year to 31 December 2025, it reported revenue of PLN 31.0m and a net loss of PLN 11.7m. At that date it held total assets of PLN 111.1m and shareholders' equity of PLN 64.6m.

Medicalgorithmics SA engages in the development of mobile electrocardiogram and arrhythmia diagnostic technology. The company is headquartered in Warsaw, Woj. Mazowieckie. The company went IPO on 2011-11-09. The firm develops and manufactures system for the diagnosis of heart arrhythmia. Its product, named PocketECG, is used for remote monitoring of cardiac disorders, arrhythmia diagnosis and monitoring of heart, as well as is used for clinical drugs trials for cardiac safety. In addition, Medicalgorithmics SA provides services in the field of information technology and biotechnology, scientific research and development of natural sciences. Moreover, the Company works on the several projects, such as a device for tele-rehabilitation cardiology, software for optimizing repetitive task in hospitals, as well as devices and systems for remote description of the electrocardiography (ECG). The company operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC and Medi-Lynx Cardiac Monitoring LLC.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
9 Nov 2011
Employees
122

Leadership

Pay as last reported

  • Mr. Michal ZoltowskiChairman of the Supervisory Board
  • Mr. Krzysztof SiemionowPresident of the Management Board, Chief Executive Officer
  • Mr. Michal WnorowskiVice Chairman of the Supervisory Board, since 2018PLN 49,000
  • Mr. Michal ZaporaChief Financial Officer, Member of the Management Board
  • Mr. Jaroslaw JerzakowskiChief Operating Officer
  • Mr. Przemyslaw TadlaChief Technology Officer, since 2025
  • Mr. Artur MalekIndependent Member of the Supervisory BoardPLN 62,000
  • Mr. Mariusz MatuszewskiIndependent Member of the Supervisory Board
  • Mr. Krzysztof UrbanowiczIndependent Member of the Supervisory BoardPLN 30,000
  • Mr. Werner EngelhardtMember of the Supervisory Board
  • Mr. Maksymilian FraszkaMember of the Supervisory Board
  • Mr. Pawel LewickiMember of the Supervisory Board

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Medicalgorithmics SA develops PocketECG for remote heart arrhythmia diagnosis and monitoring.
  • The company employs 122 full-time employees in Warsaw, Poland.
  • It operates through MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC.

Weaknesses

  • The company's IPO was on 9 November 2011, a decade ago.
  • Medicalgorithmics SA focuses on Health Care sector with limited diversification.
  • It provides services in Information Technology and biotechnology but lacks product diversity.

Opportunities

  • PocketECG is used for clinical drug trials in cardiac safety.
  • The company works on tele-rehabilitation cardiology devices for remote care.
  • Medicalgorithmics SA develops software for optimizing hospital repetitive tasks.

Threats

  • The company has no presence in the Financials or Consumer Discretionary sectors.
  • Medicalgorithmics SA's operations are limited to Health Care and Information Technology.
  • It does not operate in the Real Estate or Materials sectors.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.